• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    EssilorLuxottica Société Anonyme (ENXTPA:EL) Beat Third Quarter Expectations, Is It Still A Bargain?

    Simply Wall St·10/23/2026 15:43:58
    Listen to the news

    EssilorLuxottica Société anonyme (ENXTPA:EL) has drawn investor attention after reporting third quarter 2026 revenue of €7,486 million, up 7.2% year on year at constant exchange rates and 9.0% at current rates.

    EssilorLuxottica Société anonyme’s recent trading update has come alongside a strong rebound in the share price, with a 19.13% 7 day share price return and 22.60% 30 day share price return, even though the year to date share price return is still down 33.28% and the 1 year total shareholder return has fallen 41.90%. Meanwhile, the 3 year and 5 year total shareholder returns of 13.41% and 12.51% point to a much steadier long term journey in the background.

    Spot opportunities around EssilorLuxottica Société anonyme’s rebound by scanning a curated group of list of solid balance sheet and fundamentals (205 results) that may offer similar quality with different risk and return profiles.

    EssilorLuxottica Société anonyme’s share price has sprinted ahead of its recent lows, yet there is still a wide gap between €177.15, analysts’ €215.91 target and some intrinsic value estimates. Where does fair value really sit within that range?

    Most Popular Narrative: 21% Undervalued

    EssilorLuxottica Société anonyme’s most followed narrative points to a fair value of €223.96, which sits well above the latest close at €177.15, so the rebound still leaves a sizeable valuation gap for investors to weigh against the risks in the story.

    Strong pipeline of innovation in myopia management solutions (Stellest 2.0, DOT technology) and leadership in addressing rising vision disorders among children globally positions EssilorLuxottica to capture outsized growth from increasing myopia incidence, directly supporting future revenue and market share gains.

    Expanding global presence, especially in Asia and Latin America, leverages the growing middle class and improved healthcare access in emerging markets, opening new high-growth channels and supporting sustained top-line expansion.

    See why 37 investors see EssilorLuxottica Société anonyme as 21% undervalued.

    Result: Fair Value of €223.96 (UNDERVALUED)

    Still, EssilorLuxottica Société anonyme’s story could be knocked off course if smart eyewear adoption disappoints, or if margin pressure from tariffs and wearables persists.

    Find out about the key risks to this EssilorLuxottica Société anonyme narrative.

    Another View: What Multiples Say About EssilorLuxottica Société anonyme

    The fair value estimate of €223.96 suggests that EssilorLuxottica Société anonyme may be attractively priced, yet the current P/E of 32.6x presents a more challenging picture. It is higher than both the European Medical Equipment sector on 28x and the fair ratio of 23.4x that the market could move toward.

    If sentiment shifts closer to that fair ratio, the valuation gap would work in the opposite direction to the DCF-style upside case. For an investor weighing these signals, the key question is which reference point ultimately guides the market.

    See what the numbers indicate about this price in our valuation breakdown See what the numbers say about this price — find out in our valuation breakdown.

    ENXTPA:EL P/E Ratio as at Oct 2026
    ENXTPA:EL P/E Ratio as at Oct 2026

    Next Steps

    Sentiment around EssilorLuxottica Société anonyme is clearly divided, with risks and rewards pulling in opposite directions for investors watching closely. Act while the information is fresh and stress test the full picture for yourself by weighing 3 key rewards and 1 important warning sign.

    Looking for more investment ideas beyond EssilorLuxottica Société anonyme?

    If EssilorLuxottica Société anonyme has sharpened your focus, do not stop here. Broaden your watchlist with other opportunities that fit your risk and income goals.